Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

December 2, 1997

Primary Completion Date

December 31, 2004

Conditions
Breast Cancer
Interventions
DRUG

marimastat

Trial Locations (25)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

43206

CCOP - Columbus, Columbus

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

CentraCare Clinic, Saint Cloud

57709

Rapid City Regional Hospital, Rapid City

58201

Altru Health Systems, Grand Forks

58501

Medcenter One Health System, Bismarck

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

61801

CCOP - Carle Cancer Center, Urbana

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

07201

Trinitas Hospital - Jersey Street Campus, Elizabeth

08822

Hunterdon Regional Cancer Center, Flemington

07601

Hackensack University Medical Center, Hackensack

07962-1956

Morristown Memorial Hospital, Morristown

07701

Riverview Medical Center, Red Bank

08629

St. Francis Medical Center, Trenton

43623-3456

CCOP - Toledo Community Hospital Oncology Program, Toledo

19102-1192

Hahnemann University Hospital, Philadelphia

57105-1080

CCOP - Sioux Community Cancer Consortium, Sioux Falls

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

North Central Cancer Treatment Group

NETWORK

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003010 - Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy | Biotech Hunter | Biotech Hunter